Skip to main content
Premium Trial:

Request an Annual Quote

Karius Inks Deal to Launch Infectious Disease Test in Brazil

NEW YORK (GenomeWeb) — Karius announced today that it has signed an agreement to launch its next-generation sequencing-based infectious disease test in Brazil with medical diagnostics firm Dasa.

The recently launched test can detect over 1,000 pathogens — including bacteria, DNA viruses, fungi, mold, and protozoa — from microbial cell-free DNA in a single blood draw.

Under the terms of the deal, São Paulo-based Dasa will offer the test to hospitals in Brazil. Specimen samples from local reference laboratories in Brazil will be processed and reported at Karius' CLIA laboratory in Redwood City, California. Results are expected to be available within 48 after after samples are received.

Additional terms were not disclosed.

"Bringing the Karius test to Brazil is the first step we’re taking to make the Karius technology available to patients worldwide," Karius CEO Mickey Kertesz said in a statement.

Earlier this month, Karius' clinical collaborators presented interim study results and anecdotal evidence related to their use of the Stanford University spinout's test.

The Scan

Could Mix It Up

The US Food and Drug Administration is considering a plan that would allow for the mixing-and-matching of SARS-CoV-2 vaccines and boosters, the New York Times says.

Closest to the Dog

New Scientist reports that extinct Japanese wolf appears to be the closest known wild relative of dogs.

Offer to Come Back

The Knoxville News Sentinel reports that the University of Tennessee is offering Anming Hu, a professor who was acquitted of charges that he hid ties to China, his position back.

PNAS Papers on Myeloid Differentiation MicroRNAs, Urinary Exosomes, Maize Domestication

In PNAS this week: role of microRNAs in myeloid differentiation, exosomes in urine, and more.